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The interactions between a retrovirus and host cell chromatin that
underlie integration and provirus expression are poorly under-
stood. The prototype foamy virus (PFV) structural protein GAG
associates with chromosomes via a chromatin-binding sequence
(CBS) located within its C-terminal region. Here, we show that the
PFV CBS is essential and sufficient for a direct interaction with
nucleosomes and present a crystal structure of the CBS bound to a
mononucleosome. The CBS interacts with the histone octamer,
engaging the H2A–H2B acidic patch in a manner similar to other
acidic patch-binding proteins such as herpesvirus latency-associated
nuclear antigen (LANA). Substitutions of the invariant arginine
anchor residue in GAG result in global redistribution of PFV and
macaque simian foamy virus (SFVmac) integration sites toward cen-
tromeres, dampening the resulting proviral expression without
affecting the overall efficiency of integration. Our findings under-
score the importance of retroviral structural proteins for integra-
tion site selection and the avoidance of genomic junkyards.
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The integration of a reverse-transcribed viral genome into ahost cell chromosome is an obligatory step in the retroviral
replication cycle (reviewed in ref. 1). The fate of the resulting
provirus depends on the hospitality of the local chromatin en-
vironment, which can facilitate, moderate, or prevent viral ex-
pression (2, 3). It is not surprising, therefore, that retroviruses
evolved genus-specific and contrasting traits with respect to the
types of chromosomal loci they preferentially target. HIV-1, a
highly pathogenic lentivirus, channels integration toward gene-
dense chromosomal domains, integrating predominantly within
active transcription units (4, 5). Recent studies uncovered a hi-
erarchical mechanism that depends on HIV-1 capsid, the major
viral structural protein (a product of the viral gag gene), and
integrase, which interact with cellular proteins CPSF6 and
LEDGF/p75, respectively (6–11). Ablation of the mRNA matu-
ration factor CPSF6 results in the bulk of virus abandoning gene-
rich domains, whereas ablation of the transcriptional coactivator
LEDGF leads to a reduction of integration into transcription units
while largely preserving the virus’s ability to locate gene-rich do-
mains (11). Thus, the capsid–CPSF6 and integrase–LEDGF axes
appear to direct HIV-1 integration on the global and local scale,
respectively. Although other members of the lentivirus genus are
less studied, the similarities in their integration site distributions
and conservation of the integrase–LEDGF interaction (12–14)
suggest a shared strategy. Murine leukemia virus (MLV) and
other studied gammaretroviruses similarly target gene-dense do-
mains but tend to integrate in the immediate vicinity of promoters,
CpG islands, and DNase-hypersensitive sites (15–18). These
properties depend at least in part on the interaction between
integrase and bromodomain proteins BRD2–4 (19–21). In con-
trast, prototype foamy virus (PFV), a member of the generally
benign spumavirus retroviral genus, appears to be averse to gene-
rich regions and disfavors integration into genes (22). Encouraged
by earlier observations that PFV GAG can bind chromatin (23, 24),
we determined a crystal structure of its chromatin-binding sequence
(CBS) bound to a mononucleosome. We show that the CBS binds
at the acidic patch in the surface of H2A–H2B heterodimer via an
invariant conserved Arg anchor motif. Mutations disrupting these
contacts alter the ability of primate spumavirus GAGs to bind nu-
cleosomes and instigate global redistributions of integration sites
into centromeric regions of chromosomes.
Results
Crystal Structure of the PFV GAG CBS in Complex with a Mononucleosome.
Chromatin tethering of ectopically expressed PFV GAG depends on
the CBS, which is located in the C-terminal region of the protein
within Gly/Arg box II (GRII) (Fig. 1A) (23, 24). To test if the GAG–
chromatin interaction is direct, we purified full-length hexahistidine
(His6)-tagged PFV GAG protein and used recombinant mono-
nucleosomes assembled from bacterially expressed human histones
and 147-bp DNA with a strong positioning sequence (25). WT His6-
GAG protein readily pulled down nucleosomes on Ni-nitrilotriacetic
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acid (NTA) agarose beads (Fig. 1B, lane 1). Furthermore, bio-
tinylated CBS peptide efficiently pulled down the nucleosomes but
not free DNA on streptavidin agarose beads (Fig. 1C), indicating
that the CBS is minimally sufficient for the interaction. To visualize
the CBS–chromatin interface, we soaked nucleosome crystals in the
presence of a synthetic peptide comprising PFVGAG residues 535–
550 and collected X-ray diffraction data to 2.8-Å resolution (SI
Appendix, Table S1). The structure was solved by molecular re-
placement, and the initial difference Fo–Fc Fourier map revealed
positive density for the bound peptide (SI Appendix, Fig. S1A).
Sixteen residues of PFV GAG (Gly535–Gly550) spanning the CBS
region could be built into the map, and the model was refined to an
Rfree of 25.1% (SI Appendix, Fig. S1B and Table S1). The peptide
adopts an extended conformation, tracking across the protein side
of the nucleosome core particle (Fig. 2A). A molecular surface area
of 2,070 Å2 is buried upon the formation of the CBS–nucleosome
complex, involving one H2A–H2B heterodimer and both H3 chains.
The interactions with the H2A–H2B heterodimer account for
>75% of the GAG–nucleosome contact area. Here, the side chain
of PFV GAG Arg540 projects into the H2A–H2B acidic patch to
interact with H2A carboxylates Glu61, Asp90, and Glu92 (Fig. 2B).
GAG Tyr537 and Leu539 make hydrophobic contacts with H2A
residues Tyr57 and Ala60 as well as with H2B Val41 and Val45.
The interactions with the H2A–H2B heterodimer are further sup-
ported by hydrogen bonds between the hydroxyl group of GAG
Tyr537 and the side chains of H2B Gln44 and H2A Glu56 and,
additionally, between the main chain carbonyl of GAG Tyr544 and
the amide of H2A Glu91. CBS–histone H3 contacts primarily in-
volve GAG Tyr549, which makes hydrophobic interactions with
Leu109, Leu126, and Arg129 and also hydrogen bonds with
His113 and the main chain carboxylate of the C-terminal Ala135.
The CBS–Nucleosome Interface Is Essential for the Interaction with
Nucleosomes and Chromatin. A number of chromatin-binding
factors interact with the histone face of the nucleosome (26),
including Kaposi’s sarcoma herpesvirus (KSHV) latency-associated
nuclear antigen (LANA) (27) and centromere protein C (CENP-C)
(28). A recurrent feature of these proteins is the use of an Arg
anchor residue to make contacts with carboxylates of the H2A–
H2B acidic patch, although the rest of the interactions are not
conserved (26). The nucleosome-binding pose of PFV GAG CBS
partially overlaps with those of acidic patch binders, and Arg540,
a residue invariant among spumaviruses, plays the role of the
Arg anchor (Fig. 2 C and D). In agreement with the structures,
peptides spanning the chromatin-binding motifs of KSHV LANA
and CENP-C efficiently competed with PFV GAG CBS for nu-
cleosome binding (Fig. 1D, lanes 1–5). In contrast, the mutant
forms of the peptides, unable to interact with nucleosomes because
of substitutions of the respective Arg anchor residues, in large part
lost the ability to compete with PFV GAG (Fig. 1D, lanes 6–10).
Furthermore, substitutions of PFV GAG Tyr537, Leu539, and
Arg540 in the context of the CBS peptide or full-length protein
abolished the interaction with nucleosomes (Fig. 1 B and E).
To evaluate the importance of the CBS–nucleosome interaction
for GAG chromatin tethering, we produced HT1080 cells stably
expressing FLAG-tagged PFV and macaque simian foamy virus
(SFVmac) GAG proteins. In agreement with previous observations
(23, 24), the WT GAG proteins were nuclear and colocalized with
DNA throughout interphase and during mitosis (Fig. 3A). The
Arg anchor mutations R540Q (PFV) and R541Q (SFVmac)
abolished nuclear accumulation and chromosome binding of both
proteins. Phenocopying the CBS-deletion mutant of PFV GAG
(23, 24), both point mutants accumulated in the cytoplasm and
partly colocalized with pericentrin, a marker for the microtubule-
organizing center, during interphase (Fig. 3A and SI Appendix, Fig.
S2). In addition, SFVmac GAG R541Q appeared to decorate the
entire spindle apparatus during mitosis.
Loss of CBS Function Leads to Catastrophic Redistribution of Spumavirus
Integration Sites to Centromeric Regions. To assess the importance of
GAG tethering to chromatin during infection, we produced single-
cycle virus particles using codon-optimized constructs encoding
PFV GAG (WT or R540Q), POL (WT or catalytically inert inte-
grase mutant D185N/E221Q), and ENV along with a GFP reporter
transfer vector (29). The vector particles were purified by ultra-
centrifugation through 20% sucrose cushions and quantified by
immunoblotting using polyclonal anti-GAG antisera. Analysis of the
viral lysates with anti-integrase antibodies confirmed that the mu-
tations did not perturb the relative packaging of the structural and
enzyme components (Fig. 4). Human fibrosarcoma HT1080 cells
and MRC5 fibroblasts were infected with equal amounts of the
virus preparations and expanded to dilute nonintegrated viral DNA.
Five days postinfection, the cells were subjected to flow cytometry to
quantify the percentage of GFP+ cells, and integrated proviral DNA
content was measured by real-time PCR using primers specific to
the PFV LTR region. As expected, the D185N/E221Q active site
mutation in integrase abolished both infectivity and integration. The
substitution of the GAG Arg anchor did not affect the levels of
integrated proviral DNA but led to a twofold defect in the ability to
render target cells GFP+ (Fig. 4), suggesting a defect in viral gene
expression. When HT1080 cells were infected with concentrated
vector, a specular pattern of viral GAG antigen was readily detected
at the cell periphery when the cells were fixed immediately fol-
lowing spinoculation (0 h postinfection) (Fig. 3B). In agreement
with published observations (23, 30), 4 h postinfection GAG colo-
calized with centrosomes in every interphase cell observed and with
condensed chromosomes in mitotic cells (Fig. 3B and SI Appendix,
Fig. 1. PFV GAG CBS–nucleosome interaction in vitro. (A) Schematic rep-
resentation of PFV GAG. CBS, chromatin-binding sequence; CTRS, cytoplas-
mic targeting and retention signal; GRI-III, glycine-arginine box I-III; NES,
nuclear export signal. (B) His6-tag pull-down experiments using full-length
WT (lane 1) and indicated mutant His6-GAG constructs (lanes 2–4; LR/RL re-
versed the natural Leu539–Arg540 sequence to Arg539–Leu540). Protein and
DNA recovered on Ni-NTA beads were separated by SDS/PAGE and detected
by staining with Coomassie and ethidium bromide, respectively. Migration
positions of histones or DNA are indicated to the right of the gel. Lane
5 shows input quantity of nucleosomes used in each pull down. (C) Strep-
tavidin pull-down of nucleosomes or naked DNA with biotinylated GAG CBS
peptide in the presence of 150–300 mM NaCl (lanes 1–4). (D) Lanes 1–5:
nucleosomes incubated with biotinylated PFV GAG CBS in the absence or
presence of indicated excess WT LANA (Upper) or CENP-C (Lower) peptide.
Lanes 6–10: mutant LANA R9A and CENP-C R717A peptides deficient for
nucleosome-binding were used as specificity controls (RA). (E) Streptavidin
pull-down of nucleosomes with WT (lane 1) or mutant (lanes 2–6; LR/AA:
L539A/R540A) biotinylated PFV GAG CBS peptides.
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Fig. S3). Strikingly, although GAG R540Q PFV retained the ability
to concentrate near or on centrosomes, it failed to relocalize to
chromosomes (Fig. 3B and SI Appendix, Fig. S3), phenocopying
ectopically expressed R540Q PFV GAG-FLAG (Fig. 3A).
To test if the GAG–chromatin interactions play a role in spu-
maviral integration site selection, we mapped integration sites of
WT and R540Q PFV in a range of cell lines and compared them
with a reference set of integration sites obtained using recombi-
nant PFV intasomes and deproteinized human DNA in vitro. In
agreement with previous observations (22, 31) and in sharp con-
trast to HIV-1 and MLV, PFV disfavored integration into genes
(Fig. 5A and SI Appendix, Table S2). Thus, only 31.7% of vector
integration events mapped to transcription units in HT1080 cells,
15% lower than the levels observed for the in vitro reference
sample (46.4%, P < 10−320); results of comprehensive statistical
tests are given in Dataset S1. Furthermore, the virus showed
marked preference for integration into constitutive lamina-
associated regions (cLADs) and dark Giemsa-positive cytobands
(P < 10−320). Surprisingly, the propensity of PFV to integrate into
these deep heterochromatic regions varied widely, depending on
the nature of target cell line. Thus, although the PFV vector
showed twofold preference for integration into cLADs in
HT1080 cells, it slightly disfavored integration into these regions
in HepG2 cells (P < 10−128). Furthermore, although PFV showed
only a minor preference for integration near transcription start
sites (TSSs) (P < 10−5) and insignificant preference for CpG is-
lands in HT1080 cells (P > 0.2), it integrated into these regions
three times more frequently than expected in HepG2 cells (P <
10−320). Despite these differences, under all conditions, PFV in-
tegrated into cLADs significantly more frequently than either
HIV-1 or MLV and integrated near TSSs and CpG islands much
less frequently than MLV (P < 10−82) (Fig. 5A) (16–18, 22).
The R540Q mutation profoundly affected the distribution of
integration sites across the panel of target cell lines (Fig. 5A). The
mutant virus integrated significantly less frequently in the vicinities
of TSSs (P < 10−37) and CpG islands (P < 10−24) and preferred
regions with lower local gene densities (P < 10−15), indicating a
general retreat from loci associated with gene expression. How-
ever, although the mutation significantly stimulated integration
events into cLADs (P < 10−320) and Giemsa-positive cytobands
(P < 10−85) in HepG2 cells, it dampened them in HT1080 cells
(P < 10−175) (Fig. 5A). This unexpected discordance prompted us
to broaden the focus of the integration site analysis to a more
global scale. Inspection of integration site densities at the chro-
mosomal level revealed that the R540Q mutation led to a massive
redistribution of integration toward centromeres in all studied cell
lines (Fig. 5A). Using α-satellite–specific quantitative PCR as an
independent method, we estimated that the R540Q mutant in-
tegrated 7.8 ± 1.1 times more frequently in the vicinity of α-sat-
ellites than the WT control in HT1080 cells. Finally, to confirm
that the observed phenotypes are independent of the vector
construct or the original viral isolate, we studied integration site
distributions of non–codon-optimized vectors based on PFV and
SFVmac (32, 33). Arg anchor substitution variants of either vector
displayed twofold defects in the ability to transduce HT1080 cells
while integrating with nearly WT efficiency (SI Appendix, Fig. S4).
Furthermore, the R540Q/R541Q mutations greatly enhanced
their propensity to integrate into centromeres (Fig. 5 A and B).
Fig. 2. Crystal structure of the PFV GAG-CBS–nucleosome complex. (A) Overview of the structure. Core histones are shown as a surface representation, with
H2A in green, H2B in pale blue, H3 in orange and yellow, and H4 in cyan. DNA is shown as a cartoon colored in gray, and the GAG CBS peptide is shown as
sticks with carbon atoms in magenta. (B) Wall-eye stereoview of the CBS–histone interface. The GAG CBS peptide is shown as a stick, and histones are shown
as cartoons with select residues as sticks; hydrogen bonds are shown as dashed lines. (C) Amino acid sequence alignment of GAG CBSs from PFV, SFVmac, and
feline, equine, and bovine foamy viruses. Invariant residues are highlighted in yellow, and the Arg anchor is shown in bold; residues involved in hydrogen
bonds and hydrophobic interactions with the core histones are indicated with the magenta symbols H and ϕ, respectively. (D) Superposition in the nucle-
osome acid patch of the conserved arginine anchor motif from KHSV LANA (PDB ID code 1ZLA, cyan) (27), regulator of chromosome condensation 1 (RCC1,
PDB ID code 3MVD, green) (50), CENP-C (PDB ID code 4X23, orange) (28), Sir3 (PDB ID code 3TU4, salmon) (51), protein regulator of cytokinesis 1 (PRC1, PDB ID
code 4R8P, gray) (52), human cytomegalovirus immediate-early protein 1 (IE1) (PDB ID code 5E5A, red) (53), and PFV GAG (pink). Histones are shown in surface
representation with oxygen and nitrogen atoms in red and blue, respectively, and carbon atoms in green (H2A) or light blue (H2B).










Here we show that spumaviral GAG interacts directly with chro-
matin, engaging the H2A–H2B acidic patch via the Arg anchor
motif located within its CBS. The GAG residues involved in this
interface are critical for binding nucleosomes in vitro, and the
anchor residue Arg540 is essential for stable GAG chromatin
tethering in cells. The structure of the PFV CBS–nucleosome
complex underscores similarities as well as striking differences
among H2A–H2B acidic patch binders. Coalescing at the essential
Arg anchor residue (Fig. 2D and SI Appendix, Fig. S5), these
proteins compete for exclusive binding to a nucleosome face (Fig.
1D). At the same time, the histone surface presents ample free-
dom for the chromatin interactors to adopt a wide range of
binding configurations (SI Appendix, Fig. S5). The PFVGAG CBS
peptide tracks across the entire protein face of the nucleosome,
making contacts with highly conserved residues within core re-
gions of histones H2A, H2B, and H3. We conclude that the CBS is
a pan-nucleosome binder, and, although it is essential to maintain
the observed primate spumavirus integration site distribution
profiles (Fig. 5A and B), it is unlikely to determine them. Similarly,
the structure of the PFV intasome bound to the nucleosome core
particle highlighted conserved nucleosome features that are
critical for integration into chromatin but do not explain the ob-
served integration site profiles (22). The propensity of R540Q
GAG to persist near centrosomes (Fig. 3 A and B) provides a clue
as to why the mutant viral integration sites cluster around cen-
tromeres: As chromosomes approach centrosomes at the end of
mitosis, the centromeric regions could come in closer contact with
the viral nucleoprotein complexes. Binding of GAG to centro-
somes is integral to intracellular trafficking and biogenesis of the
spumavirus (34–36), and it would be of interest to identify the
centrosomal receptor for spumaviral GAG.
In contrast to spumaviruses, orthoretroviral GAG proteins are
processed during viral maturation into separate polypeptides,
including capsid, as well as into a range of smaller accessory
proteins. P12 is an essential product of the gammaretroviral gag
gene and is a component of the MLV preintegration complex
(37, 38). In striking similarity to PFV GAG, MLV P12 associates
with mitotic chromosomes, and this property depends on an Arg-
rich motif within its C-terminal region (39). Although deletions
of or substitutions within this putative nucleosome-binding re-
gion abolish MLV infectivity, its replacement with heterologous
chromatin-binding peptides, such as the PFV GAG CBS, are
tolerated (39, 40). Thus the loss of chromatin-tethering function
via a gag product seems to be even more catastrophic for MLV
than for the spumaviruses, which retain the ability to complete
integration upon CBS abrogation (Fig. 4 and SI Appendix, Fig.
S4) (23). In this regard, the phenotype of the spumaviral GAG
CBS mutants is more similar to those of HIV-1, which display
dramatic redistributions of integration sites away from gene-rich
chromosomal domains without severe loss of virus titer when capsid
binding to the mRNAmaturating factor CPSF6 is disrupted (10, 11,
Fig. 3. The Arg anchor residue is essential for chromosomal tethering of PFV
and SFVmac GAG. (A) HT1080 cells stably expressing FLAG-tagged PFV (WT or
R540Q) (Left) or SFVmac GAG (WT or R541Q) (Right) were stained with anti-
FLAG (green) or anti-pericentrin antibody (red); DNA was visualized with DAPI
(blue). (B) GAG localization during PFV infection. HT1080 cells infected with PFV
vector by spinoculation at 4 °C were fixed immediately or after 4-h incubation
at 37 °C. GAG was detected using polyclonal anti-PFV Gag antiserum (green);
pericentrin (red) and chromosomal DNA (blue) were visualized as in A.
Fig. 4. Infectivity analyses of the PFV GAG R540Q mutant. Equivalent amounts
of PFV vector particles carrying WT or R540Q GAG or catalytically inert D185N/
E221Q integrase (NQ) were used to infect HT1080 or MRC5 cells. Five days
postinfection, the total proviral content was measured by quantitative real-time
PCR, and GFP+ cells were counted by flow cytometry as relative measures of
successful integration and infectivity, respectively. The bar charts represent mean
relative values from a series of infections with varied viral inputs normalized by
GAG protein content and resulting in ∼5–50%GFP conversion in theWT sample.
Error bars are SDs determined from at least three independent infections; the
WT values in each experiment were set to 100%. Immunoblots detecting GAG
isoforms (pr71 and p68) and integrase are shown in the middle.
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41, 42). Our findings highlight that the involvement of GAG in
integration site selection is conserved in both retroviral subfamilies,
despite the great evolutionary distance separating them.
Primate spumaviruses have broad host-tissue tropism and are
capable of replicating in a wide range of cell types in vitro (43, 44),
although the most active viral replication appears to occur in su-
perficial epithelium (45). Comparison of PFV integration site
profiles in our panel of human cell lines revealed unexpected
variability, with HT1080 fibrosarcoma and HepG2 hepatocytes on
opposing sides of the spectrum. Thus, although PFV integration is
strongly biased toward deep heterochromatic regions, such as
cLADs, in HT1080, it largely avoids them in HepG2. The con-
verse is true for TSSs and CpG islands, which become strongly
preferred in HEK293T, MRC5 fibroblasts, and even more so in
HepG2 cells. Moreover, in the latter cell line, the virus appears to
lose its ability to discriminate against highly active transcription
units, a trait that is highly prominent in HT1080 cells (Fig. 5A)
(22). Nevertheless, in all cell lines studied here (Fig. 5A and SI
Appendix, Table S2), as well as in primary fibroblasts and hema-
topoietic cells (31), PFV disfavors integration into transcription
units and integrates into regions of considerably lower gene den-
sity than the lentivirus HIV-1 or the gammaretrovirus MLV (Fig.
5A). Spumaviral infection is not associated with severe pathology,
and perhaps this retroviral subfamily evolved to self-moderate by
integrating into less active regions of host cell genomes. It is tempting
to speculate that, akin to lentiviruses and gammaretroviruses, spu-
maviruses use chromatin-associated host factor(s), possibly recognized
by integrase, to facilitate integration site selection. Variable expression
of a targeting factor could explain the observed differences in inte-
gration profiles among the studied cell lines.
We have not been able to detect interaction between the PFV
intasome and GAG, and their respective interfaces with the
nucleosome do not overlap (Fig. 2A and ref. 22). It is possible
that GAG could associate with the preintegration complex as a
consequence of its ability to bind nucleic acids (24). Alterna-
tively, the GAG–chromatin interface may occur before viral
capsid uncoating and preintegration complex assembly. Our data
show that GAG–chromosomal tethering is critical to the virus’s
ability to avoid genomic junkyards, such as centromeric regions.
On the face of the massive redistribution of integration sites
toward centromeres, it is not surprising that the R540Q vectors
displayed a significant reduction in transgene expression (Fig. 4
and SI Appendix, Fig. S4).
Materials and Methods
Recombinant PFV and SFVmac GAG proteins and human histones were pro-
duced in bacteria and purified as detailed in SI Appendix, SI Materials and
Methods. Mononucleosomes were assembled using a DNA construct with the
Widom 601 positioning sequence (25) and crystallized according to established
procedures (46). The vector and in vitro integration sites were sequenced using
linker-mediated PCR in conjunction with the Illumina technology as described
(4, 47, 48). Additional experimental details are given in SI Appendix, SI Ma-
terials and Methods.
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Fig. 5. Integration site distribution of arginine anchor motif-mutant virus particles. (A) Integration frequency of the indicated viruses near annotated ge-
nomic features expressed as odds ratios and shown in a heatmap. Enriched features (odds ratio >1) compared with reference are highlighted in red, and
depleted features (odds ratio <1) are shown in blue, as indicated by the legend to the right. Raw data are given in SI Appendix, Table S2. HIV-1 and MLV
integration sites in HEK293T cells alongside the matched random control simulated data were from published work (11). HT1080, HEK293T, MRC5, or
HepG2 cell line-specific gene-expression activity was reported previously (GEO accession codes GSE58968, GSE11892, GSE63577, and GSE87958) (54–57). All
observable differences betweenWT and the corresponding mutant data were statistically significant (P < 0.05) (Dataset S1). (B) PFV (WT or R540Q) and SFVmac
(WT or R541Q) integration site density along human chromosome 7 in a sliding window of 500 Mbp. Integration site densities of WT and mutant vectors are
shown as blue and orange traces respectively.
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